Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9603 posts found.

NICE approves Erbitux for colon cancer

June 1, 2009 Research and Development, Sales and Marketing Erbitux, NICE

NICE has approved Merck Serono's Erbitux, making it a first-line therapy for many patients with a certain type of metastatic …
News

Companies poised for swine flu vaccine drive

May 29, 2009 Research and Development, Sales and Marketing US, h1n1, vaccines

Pharmaceutical manufacturers now have access to the swine flu seed virus that can be used to start full-blown production of …
News

Sanofi adds to cancer pipeline with Exelixis deal

May 28, 2009 Research and Development, Sales and Marketing Sanofi-Aventis

Sanofi-Aventis has signed a deal with oncology-focused biotech Exelixis to co-develop two new cancer treatments.The alliance will see Sanofi gain …
News

Italian CRO Pierrel plans acquisitions

May 28, 2009 Research and Development Pierrel

Italian contract research and manufacturing company Pierrel has signed two separate deals to bolster its capabilities in the clinical research …
News

New funding for NHS research projects

May 28, 2009 Research and Development NHS

Projects ranging from diagnostics to diabetes care and genotyping have been given government funding as part of a new award …
News

Johnson & Johnson to buy Cougar Biotechnology

May 27, 2009 Research and Development, Sales and Marketing Cougar, J&J, JJ

Johnson & Johnson is to buy Los Angeles-based biotech firm Cougar Biotechnology for $970 million.The purchase, expected to go through …
News

UK government ignores biotech pleas for cash

May 27, 2009 Research and Development biotech

The UK biotech sector says the government's failure to provide urgently needed financial assistance is jeopardising its future.Industry body the …
News

Quotient buys Scottish clinical unit from Charles River

May 26, 2009 Research and Development Charles River, Quotient

Contract research organisation Quotient Bioresearch has acquired a facility from Charles River Laboratories that will boost its capabilities in the …
News

Phase III drug superior to Spiriva, says Novartis

May 21, 2009 Research and Development, Sales and Marketing COPD, Novarits

Novartis says its COPD treatment has shown significant benefits over two established rivals, and could form the cornerstone of a …
News

Mexican flu: contained but not beaten

May 21, 2009 Research and Development Mexico, Vaccine, flu, pandemic

Global efforts to limit the impact of the new strain of H1N1 flu virus have proven successful, but the threat …
Feature

Takeda to market new bone cancer drug

May 20, 2009 Research and Development, Sales and Marketing MA, Takeda

Takeda has gained the rights to the first treatment for a new malignant bone cancer affecting children and young adults. …
News

Cannabis-derived MS drug filed for European approval

May 20, 2009 Research and Development, Sales and Marketing GW, Sativex

Sativex, the cannabis-derived product developed by GW Pharmaceuticals, could be finally set for European approval after five years of delay. …
News

EFPIA plans counterfeit crackdown

May 20, 2009 Manufacturing and Production, Research and Development EFPIA, counterfeits

 European pharmaceutical industry association EFPIA has unveiled a new scheme to crack down on counterfeit medicines.Beginning with a trial run …
News

SkyePharma cuts staff at French and Swiss facilities

May 20, 2009 Research and Development, Sales and Marketing Skyepharma

SkyePharma has moved ahead with plans to cut its workforce at a manufacturing plant in France by a third as …
News

The medical-marketing interface and how to bridge the gap

May 18, 2009 Research and Development, Sales and Marketing marketing, medical

Drug companies are not charities and are accountable to their shareholders, as we all know. Products have to be sold …
Feature
The Gateway to Local Adoption Series

Latest content

Thermo Fisher opens new distribution centre in Ireland

March 12, 2026

Altimetrik appoints Dhirendra Nath as Chief Human Resources Officer

March 12, 2026

Kindeva appoints Mike Cowhig as Chief Legal Officer

March 11, 2026

DiaMedica gets regulatory clearance from Health Canada for phase 2 preeclampsia study

March 11, 2026

Abselion establishes a US subsidiary in Massachusetts 

March 10, 2026